Morgan Stanley Bristol Myers Squibb CO Cont V Transaction History

Morgan Stanley

  • $1.59 Trillion
  • Q3 2025

A detailed history of Morgan Stanley transactions in Bristol Myers Squibb CO Cont V stock. As of the latest transaction made, Morgan Stanley holds 119 shares of CELGRT stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119
Previous 119 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

May 14, 2025
SELL
N/A
-45 Reduced 27.44%
119 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-45 Reduced 27.44%
119 $0
Q2 2024

May 14, 2025
BUY
N/A
45 Added 37.82%
164 $0
Q3 2022

Nov 14, 2022
BUY
N/A
59 Added 56.19%
164 $0
Q3 2021

Nov 15, 2021
BUY
N/A
105 New
105 $0

Others Institutions Holding CELGRT

# of Institutions
23
Shares Held
1.22M
Call Options Held
0
Put Options Held
0
View Full List

About BRISTOL MYERS SQUIBB CO CONT V

CELGRT Quotes by TradingView
  • Ticker CELGRT
More about CELGRT
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email